Sigilon Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2021 to Q2 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Sigilon Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q2 2023.
  • Sigilon Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2023 was 228 %, a 29.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2023 228 -94.7 -29.3% Jun 30, 2023
Q1 2023 252 -95.8 -27.6% Mar 31, 2023
Q4 2022 271 -130 -32.5% Dec 31, 2022
Q3 2022 301 -117 -28% Sep 30, 2022
Q2 2022 323 Jun 30, 2022
Q1 2022 348 Mar 31, 2022
Q4 2021 401 Dec 31, 2021
Q3 2021 418 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.